Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
29 août 2023 08h30 HE
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will...
Correction: Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
27 avr. 2023 10h14 HE
|
Nuvectis Pharma, Inc.
FORT LEE, NJ, April 27, 2023 (GLOBE NEWSWIRE) -- In the news release, Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference, please note that the conference date is...
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
27 avr. 2023 08h00 HE
|
Nuvectis Pharma, Inc.
FORT LEE, NJ, April 27, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the...
GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
24 févr. 2023 09h00 HE
|
GT Biopharma, Inc.
BRISBANE, CALIFORNIA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the...
Freight Technologies, Inc., to Participate in H.C. Wainwright 24th Annual Global Investment Conference
14 sept. 2022 07h05 HE
|
Freight Technologies Inc
HOUSTON, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Freight Technologies, Inc. (Nasdaq: FRGT, Fr8Tech), a technology company developing solutions to optimize and automate the supply...
Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13
12 sept. 2022 18h30 HE
|
Celsion Corporation
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief...
MetaWorks Announces Participation at the H.C. Wainwright 24th Annual Global Investment Conference
09 sept. 2022 16h30 HE
|
MetaWorks Platforms, Inc
Fairfield, CA., Sept. 09, 2022 (GLOBE NEWSWIRE) -- MetaWorks Platforms, Inc. (“MetaWorks” or the “Company”), (CSE: MWRK and OTCQB: MWRK), an award-winning, full-service Web3 blockchain platform...
CareCloud to Present at the H.C. Wainwright 24th Annual Global Investment Conference on Monday, September 12
09 sept. 2022 08h30 HE
|
CareCloud, Inc
SOMERSET, N.J., Sept. 09, 2022 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems...
Locafy to Present at the H.C. Wainwright 24th Annual Global Investment Conference
09 sept. 2022 08h00 HE
|
Locafy Limited
PERTH, Australia, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Locafy Limited (Nasdaq: LCFY, LCFYW) (“Locafy” or “the Company”), a globally recognized software-as-a-service technology company specializing in...
InflaRx to Present at Upcoming Scientific and Investor Conferences
09 sept. 2022 07h30 HE
|
InflaRx N.V.
JENA, Germany, Sept. 09, 2022 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement...